1Jaemal A, Thomas A, Murray T, et al. Cancer statistic 2002. CA Cancer J Clin, 2002,52: 23-47. 被引量：1
2Isurugi K, Suzuki Y, Tanjz S, et al. Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patientwith bladder cancer. J Urol,2002,168: 1574-1577. 被引量：1
3Muller M, Krause H, Heicappell R, et al. Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer. Clin Cancer Res,1998,4: 1949-1954. 被引量：1
4Yoshida K, Sugino K, Tahara H. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer,1997,79:362-366. 被引量：1
5Lance R S, Aldous W K, Blaser J, et al. Telomerase activity in solid transitional cell carcinoma, bladder washings, and voided urine. Urol Oncol, 1998,4: 43-49. 被引量：1
6Lin B C, Loughlin K R. Telomerase in human bladder cancer. Urol Clin North Am,2000, 27: 115-123. 被引量：1
7Cassel A, Rahat M A, Lahat N, et al. Telomerase activity and cytokeratin 20 as markers for the detection and follow up of transitional cell carcinoma: An unfulfilled promise. J Urol, 2001, 163: 841-844. 被引量：1
8Lokeshwar V B, Obek C, Lida N, et al. Tumor-associated hyaluronic acid: a sensitive and specific urine marker for bladder cancer. Cancer Res, 1997,57: 773-777. 被引量：1
9Hautman S H, Lokeshwar V B, Schroeder G L, et al. Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-Haase urine test for bladder cancer. J Urol, 2001,165: 2068-2074. 被引量：1
10Keesee S K, Briggman J V, Thill G, et al. Utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukayotic Gene Expr,1996,6: 189-214. 被引量：1
2Shariat SF, Casella R, Khoddami SM, et al. Urine survivin detection is a sensitive marker for the noninvasive diagnosis of bladder cancer [J].J Urol, 2004, 171(2pt1) : 626 -630. 被引量：1
3Garcia RL, Coltrera MD, Gown AW. Analysis of proliferative grade using anti -PCNA/cyclin monoclonal antibodies in fixed, embedded tissues: comparison with flow cytometric analysis [ J ]. Am J Pathol, 1989,134:733 - 738. 被引量：1
4McKay TR, Bell S, Tenev T, et al. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant - negative mutant, survivin T34A; a combination gene therapy strategy [ J ]. Oncogene, 2003, 22 ( 23 ) : 3539 - 3547. 被引量：1
5Suzuki A, Ito T, Kawano H, et al. Survivin initiates procaspase 3/ p21 complex formation as a result of interaction with Cdk4to resist Fas - mediated cell death[ J ]. Oncogene, 2000,19, 1346 - 1353. 被引量：1
6Kubben F J, Haesevocts AP,Engels IG, et al. PCNA : a new marker to study human colonic cell proliferative [ J ]. Gut, 1994,35:530. 被引量：1
